QQQ   298.44 (-1.16%)
AAPL   145.54 (-1.07%)
MSFT   261.50 (+0.15%)
FB   200.04 (+0.71%)
GOOGL   2,288.90 (-1.38%)
AMZN   2,216.21 (-1.99%)
TSLA   724.37 (-5.88%)
NVDA   172.64 (-2.50%)
BABA   86.48 (-1.72%)
NIO   14.55 (+1.68%)
AMD   94.24 (-0.93%)
CGC   5.73 (-3.21%)
MU   70.47 (-2.02%)
T   20.28 (+2.22%)
GE   74.63 (-0.56%)
F   13.05 (-3.33%)
DIS   105.18 (-2.00%)
AMC   11.71 (-0.85%)
PFE   50.67 (+1.50%)
PYPL   77.65 (-1.50%)
NFLX   186.51 (-0.60%)
QQQ   298.44 (-1.16%)
AAPL   145.54 (-1.07%)
MSFT   261.50 (+0.15%)
FB   200.04 (+0.71%)
GOOGL   2,288.90 (-1.38%)
AMZN   2,216.21 (-1.99%)
TSLA   724.37 (-5.88%)
NVDA   172.64 (-2.50%)
BABA   86.48 (-1.72%)
NIO   14.55 (+1.68%)
AMD   94.24 (-0.93%)
CGC   5.73 (-3.21%)
MU   70.47 (-2.02%)
T   20.28 (+2.22%)
GE   74.63 (-0.56%)
F   13.05 (-3.33%)
DIS   105.18 (-2.00%)
AMC   11.71 (-0.85%)
PFE   50.67 (+1.50%)
PYPL   77.65 (-1.50%)
NFLX   186.51 (-0.60%)
QQQ   298.44 (-1.16%)
AAPL   145.54 (-1.07%)
MSFT   261.50 (+0.15%)
FB   200.04 (+0.71%)
GOOGL   2,288.90 (-1.38%)
AMZN   2,216.21 (-1.99%)
TSLA   724.37 (-5.88%)
NVDA   172.64 (-2.50%)
BABA   86.48 (-1.72%)
NIO   14.55 (+1.68%)
AMD   94.24 (-0.93%)
CGC   5.73 (-3.21%)
MU   70.47 (-2.02%)
T   20.28 (+2.22%)
GE   74.63 (-0.56%)
F   13.05 (-3.33%)
DIS   105.18 (-2.00%)
AMC   11.71 (-0.85%)
PFE   50.67 (+1.50%)
PYPL   77.65 (-1.50%)
NFLX   186.51 (-0.60%)
QQQ   298.44 (-1.16%)
AAPL   145.54 (-1.07%)
MSFT   261.50 (+0.15%)
FB   200.04 (+0.71%)
GOOGL   2,288.90 (-1.38%)
AMZN   2,216.21 (-1.99%)
TSLA   724.37 (-5.88%)
NVDA   172.64 (-2.50%)
BABA   86.48 (-1.72%)
NIO   14.55 (+1.68%)
AMD   94.24 (-0.93%)
CGC   5.73 (-3.21%)
MU   70.47 (-2.02%)
T   20.28 (+2.22%)
GE   74.63 (-0.56%)
F   13.05 (-3.33%)
DIS   105.18 (-2.00%)
AMC   11.71 (-0.85%)
PFE   50.67 (+1.50%)
PYPL   77.65 (-1.50%)
NFLX   186.51 (-0.60%)
NASDAQ:AVXL

Anavex Life Sciences News Headlines

$8.72
+0.13 (+1.51%)
(As of 05/16/2022 04:00 PM ET)
Add
Compare
Today's Range
$8.44
$9.12
50-Day Range
$7.31
$13.10
52-Week Range
$7.13
$31.50
Volume
630,666 shs
Average Volume
1.10 million shs
Market Capitalization
$670.72 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.93
Get Anavex Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVXL and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

Anavex Life Sciences Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AVXL
News Sentiment

0.60

0.48

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AVXL Articles
This Week

14

1

AVXL Articles
Average Week



Anavex Life Sciences (NASDAQ:AVXL) News Headlines Today

SourceHeadline
marketbeat.com logoAnavex Life Sciences (NASDAQ:AVXL) Upgraded to "Buy" at Zacks Investment Research
marketbeat.com - May 13 at 5:40 PM
marketbeat.com logoFY2022 EPS Estimates for Anavex Life Sciences Corp. Raised by Cantor Fitzgerald (NASDAQ:AVXL)
marketbeat.com - May 13 at 9:34 AM
MarketBeat logoZacks Investment Research Upgrades Anavex Life Sciences (NASDAQ:AVXL) to Buy
americanbankingnews.com - May 15 at 3:38 AM
MarketBeat logoFY2022 EPS Estimates for Anavex Life Sciences Corp. Increased by Cantor Fitzgerald (NASDAQ:AVXL)
americanbankingnews.com - May 14 at 3:56 AM
benzinga.com logoBragar Eagel & Squire, P.C. Is Investigating Anavex, Koppers, Core Scientific, and Agrify and Encourages Investors to Contact the Firm
benzinga.com - May 11 at 9:28 PM
fool.com logoAnavex Life Sciences (AVXL) Q2 2022 Earnings Call Transcript
fool.com - May 11 at 7:00 PM
finance.yahoo.com logoAnavex Life Sciences Provides Business Update and Reports Fiscal 2022 Second Quarter Financial Results
finance.yahoo.com - May 10 at 7:36 AM
seekingalpha.com logoAnavex Life Sciences Q2 2022 Earnings Preview
seekingalpha.com - May 9 at 9:12 PM
MarketBeat logoAnavex Life Sciences (AVXL) to Release Earnings on Tuesday
americanbankingnews.com - May 9 at 5:18 AM
MarketBeat logoAnavex Life Sciences (NASDAQ:AVXL) Reaches New 12-Month Low at $8.41
americanbankingnews.com - May 8 at 3:45 AM
finance.yahoo.com logoAnavex Life Sciences to Announce Fiscal 2022 Second Quarter Financial Results on Tuesday May 10, 2022
finance.yahoo.com - May 3 at 9:43 AM
apnews.com logoAnavex Life Sciences Invited to Present at the B. Riley Securities’ 2022 Virtual Neuro & Ophthalmology Conference
apnews.com - April 26 at 1:18 PM
finance.yahoo.com logoAnavex Life Sciences Invited to Present at the B. Riley Securities' 2022 Virtual Neuro & Ophthalmology Conference
finance.yahoo.com - April 26 at 8:14 AM
finance.yahoo.com logoAnavex Life Sciences to Participate in the Cantor Virtual Rare Orphan Disease Summit
finance.yahoo.com - March 28 at 8:07 AM
finance.yahoo.com logoAnavex Life Sciences Announces Presentation of Phase 2 Clinical Biomarker Data from ANAVEX®2-73-PDD-001 Parkinson’s Disease Dementia Study at AD/PD™ 2022 International Conference
finance.yahoo.com - March 15 at 9:10 AM
apnews.com logoINVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Anavex Life Sciences Corp. (AVXL) on Behalf of Investors
apnews.com - March 8 at 7:49 AM
fool.com logoAnavex Life Sciences(AVXL)
fool.com - March 6 at 6:22 PM
finance.yahoo.com logoAnavex Life Sciences Announces Change of Auditor to Grant Thornton LLP
finance.yahoo.com - March 4 at 4:36 PM
finance.yahoo.com logoAnavex Life Sciences Provides Supplemental Information on ANAVEX®2-73 (Blarcamesine) AVATAR Phase 3 Trial for the Treatment of Adult Patients with Rett Syndrome
finance.yahoo.com - February 4 at 7:52 AM
finance.yahoo.com logoAnavex Life Sciences to Announce Fiscal 2022 First Quarter Financial Results on Wednesday, February 9, 2022
finance.yahoo.com - February 3 at 9:00 AM
morningstar.com logoINVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $100,000 to Contact the Firm
morningstar.com - February 2 at 3:42 PM
finance.yahoo.com logoAnavex CEO Says 'Inaccurate Impression' Clouded Rett Drug's Promise
finance.yahoo.com - February 1 at 7:09 PM
finance.yahoo.com logoAnavex Life Sciences Says Rett Syndrome Trial Meets Primary & Secondary Goals
finance.yahoo.com - February 1 at 2:08 PM
finance.yahoo.com logoAnavex Life Sciences Crashes As Last-Minute Testing Edits Cloud Drug's Impact
finance.yahoo.com - February 1 at 2:08 PM
seekingalpha.com logoAnavex says late-stage trial for Rett syndrome met main goals
seekingalpha.com - February 1 at 9:08 AM
finance.yahoo.com logoANAVEX®2-73 (Blarcamesine) AVATAR Phase 3 Trial met Primary and Secondary Efficacy Endpoints for the Treatment of Adult Patients with Rett Syndrome
finance.yahoo.com - February 1 at 9:08 AM
nasdaq.com logoNoteworthy Friday Option Activity: AVXL, LMND, AMAT
nasdaq.com - January 28 at 4:18 PM
nasdaq.com logoFirst Week of March 4th Options Trading For Anavex Life Sciences (AVXL)
nasdaq.com - January 18 at 12:35 PM
nasdaq.com logoWhen Can We Expect A Profit From Anavex Life Sciences Corp. (NASDAQ:AVXL)?
nasdaq.com - January 5 at 8:20 AM
finance.yahoo.com logoAnavex Life Sciences to Present at the H.C. Wainwright Virtual BioConnect 2022 Conference
finance.yahoo.com - January 5 at 8:20 AM
finance.yahoo.com logoIs the Options Market Predicting a Spike in Anavex (AVXL) Stock?
finance.yahoo.com - December 29 at 10:43 AM
msn.com logoThe Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus In Final Week Of Year
msn.com - December 26 at 12:51 PM
finance.yahoo.com logoAnavex Life Sciences Corp. (NASDAQ:AVXL): Is Breakeven Near?
finance.yahoo.com - December 9 at 8:04 AM
finance.yahoo.com logoAnavex Life Sciences Provides Business Update and Reports Fiscal 2021 Year End Financial Results
finance.yahoo.com - November 24 at 7:42 AM
nasdaq.com logoNoteworthy Tuesday Option Activity: AVXL, JWN, NEE
nasdaq.com - November 23 at 5:57 PM
benzinga.com logoEarnings Outlook For Anavex Life Sciences
benzinga.com - November 23 at 5:57 PM
finance.yahoo.com logoAnavex Life Sciences to Announce Fiscal 2021 Year End Financial Results on Wednesday, November 24, 2021
finance.yahoo.com - November 17 at 7:15 AM
finance.yahoo.com logoAnavex Life Sciences Announces Participation at Upcoming Lausanne VIII Workshop Panel - Building Global Momentum for Interventions in Alzheimer’s Disease
finance.yahoo.com - November 10 at 7:43 AM
finance.yahoo.com logo2 Biotech Stocks Set to Go Supernova Soon
finance.yahoo.com - October 18 at 8:35 AM
finance.yahoo.com logoAnavex Life Sciences to Present at the Dawson James Securities 6th Annual Conference
finance.yahoo.com - October 15 at 7:24 AM
uk.finance.yahoo.com logoAnavex Life Sciences (NASDAQ:AVXL) Is In A Strong Position To Grow Its Business
uk.finance.yahoo.com - August 28 at 2:56 PM
finance.yahoo.com logoAnavex Life Sciences Announces Publication of Foundational Data for ANAVEX®2-73 (blarcamesine) in Fragile X Syndrome (Autism)
finance.yahoo.com - August 26 at 9:12 AM
finance.yahoo.com logoAnavex Life Sciences Provides Business Update and Reports Fiscal 2021 Third Quarter Financial Results
finance.yahoo.com - August 12 at 7:59 AM
finance.yahoo.com logoAnavex Life Sciences to Announce Fiscal 2021 Third Quarter Financial Results on Thursday, August 12, 2021
finance.yahoo.com - August 5 at 7:13 AM
finance.yahoo.com logoAnavex Life Sciences CEO discusses trials of new Parkinson's and dementia drugs
finance.yahoo.com - July 26 at 2:30 PM
markets.businessinsider.com logoCramer Shares His Thoughts On Anavex Life Sciences, Upstart And More
markets.businessinsider.com - July 9 at 12:46 PM
finance.yahoo.com logo[video]Our Technical Strategy for Speculative Anavex Life Sciences
finance.yahoo.com - July 9 at 12:46 PM
benzinga.com logoAnavex Life Sciences Stock Rallies: Technical Levels To Watch
benzinga.com - June 28 at 6:28 PM
markets.businessinsider.com logoWhy This Anavex Life Sciences Analyst Is Lifting Their Price Target
markets.businessinsider.com - June 28 at 6:28 PM
finance.yahoo.com logoAnavex Higher on Phase 2 Progress With Parkinson's Drug
finance.yahoo.com - June 28 at 1:08 PM
finance.yahoo.com logoWhy Anavex Life Sciences Shares Are Up 17% Today
finance.yahoo.com - June 28 at 1:08 PM
finance.yahoo.com logoAnavex Life Sciences Announces ANAVEX®2-73 (Blarcamesine) Improved both Primary Cognitive and Secondary MDS-UPDRS Efficacy Endpoints with Significant Biomarker Correlation in Placebo-Controlled Phase 2 Clinical Trial for the Treatment of Patients with Parkinson’s Disease Dementia
finance.yahoo.com - June 28 at 8:08 AM
Get Anavex Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVXL and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 5/16/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.